| ［1］ |
Tso S, Satchwell F, Moiz H, et al. Erythroderma （exfoliative dermatitis）. Part 1: underlying causes, clinical presentation and pathogenesis［J］. Clin Exp Dermatol, 2021,46（6）:1001⁃1010. doi: 10.1111/ced.14625.
|
| ［2］ |
Dubin C, Del Duca E, Guttman⁃Yassky E. The IL⁃4, IL⁃13 and IL⁃31 pathways in atopic dermatitis［J］. Expert Rev Clin Immunol, 2021,17（8）:835⁃852. doi: 10.1080/1744666X.2021.1940962.
|
| ［3］ |
Olbrich H, Sadik CD, Ludwig RJ, et al. Dupilumab in inflammatory skin diseases: a systematic review［J］. Biomolecules, 2023,13（4）:634. doi: 10.3390/biom13040634.
|
| ［4］ |
周亦若, 程浩, 王一枫. 度普利尤单抗联合糖皮质激素治疗药疹1例［J］. 中国现代医生, 2023,61（1）:141⁃142. doi: 10.3969/j.issn.1673⁃9701.2023.01.032.
|
